Advait Gupta

5682 POSTS
Advait is our expert writer and manager for the Artificial Intelligence category. His passion for AI research and its advancements drives him to deliver in-depth articles that explore the frontiers of this rapidly evolving field. Advait's articles delve into the latest breakthroughs, trends, and ethical considerations, keeping readers at the forefront of AI knowledge.

Exclusive articles:

Observe.ai Introduces Contact Center LLM with 30-Billion-Parameter and Generative AI Product Suite

Discover Observe.ai's 30-billion-parameter capacity language model, specially calibrated for contact centers. Empower agents to enhance performance and customer experience. Learn more now.

Meta’s Belated AI Arrival futile to Beat ChatGPT

Meta, formerly Facebook, is falling behind in the AI race, losing a third of its staff in 2022 due to burnout and leadership issues. Despite its impressive technologies, the company lags behind competitors.

5 Essential Tools Every Business and SEO Specialist Needs in 2023

Enhance your SEO strategy with these must-have tools for 2023! From keyword research to social media management, investing in the right tools can simplify the process and lead to success.

Transform Your Doodles into Art on Your Phone with AI Technology

Qualcomm has announced ControlNet, a new AI image generation model that can enhance images starting with a seed image and without requiring an internet connection. The future is here with ControlNet.

Let’s critically discuss generative AI in a peer-to-peer setting now.

Join VB Transform's flagship event to learn about the growing trend of generative AI and gain insights from industry leaders. Network, attend roundtable events and explore innovative solutions shaping the future of AI. Don't miss out on this opportunity to stay ahead of the curve.

Breaking

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.
spot_imgspot_img